共 14 条
- [1] Comment on Campana et al.: Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 174 - 175
- [2] Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence: response to comments by Ezziddin et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (01) : 176 - 177
- [3] Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence: response to comments by Ezziddin et al. European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 176 - 177
- [5] Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 1197 - 1205
- [7] Response to comment on "Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda (Oyella et al. 2012)" JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15
- [10] Comment on “Serum human epididymis protein 4 is associated with the treatment response of concurrent chemo-radiotherapy and prognosis in patients with locally advanced non-small cell lung cancer” by Lan WG et al. Clinical and Translational Oncology, 2018, 20 : 801 - 802